Manhattan Medical Research   Report issue

For profit Phase 3 Phase 4
Founded: New York NY United States (2013)

Organization Overview

First Clinical Trial
2013
NCT01887678
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Manhattan Medical Research Practice | Manhattan Medical Research Practice, PLLC

Active Ingredients

Drugs in Phase 4 Trials (1)

collagenase clostridium histolyticum (xiaflex) (1 trial)

Drugs in Phase 3 Trials (3)

testosterone (delatestryl) (2 trials)

traumeel (1 trial)

zeel (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypogonadism (Phase 3)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Penile Induration (Phase 4)

Recurrence (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4